TY - JOUR
T1 - Mutations in GNAL: A novel cause of craniocervical dystonia
AU - Kumar, Kishore R.
AU - Lohmann, Katja
AU - Masuho, Ikuo
AU - Miyamoto, Ryosuke
AU - Ferbert, Andreas
AU - Lohnau, Thora
AU - Kasten, Meike
AU - Hagenah, Johann
AU - Brüggemann, Norbert
AU - Graf, Julia
AU - Münchau, Alexander
AU - Kostic, Vladimir S.
AU - Sue, Carolyn M.
AU - Domingo, Aloysius R.
AU - Rosales, Raymond L.
AU - Lee, Lilian V.
AU - Grütz, Karen
AU - Westenberger, Ana
AU - Mukai, Youhei
AU - Kawarai, Toshitaka
AU - Kaji, Ryuji
AU - Klein, Christine
AU - Martemyanov, Kirill A.
AU - Schmidt, Alexander
PY - 2014/4/1
Y1 - 2014/4/1
N2 - IMPORTANCE: Mutations in the GNAL gene have recently been shown to cause primary torsion dystonia. The GNAL-encoded protein (Gαolf) is important for dopamine D1receptor function and odorant signal transduction.We sequenced all 12 exons of GNAL in 461 patients from Germany, Serbia, and Japan, including 318 patients with dystonia (190 with cervical dystonia), 51 with hyposmia and Parkinson disease, and 92 with tardive dyskinesia or acute dystonic reactions. OBSERVATIONS: We identified the following two novel heterozygous putative mutations in GNAL: p.Gly213Ser in a German patient and p.Ala353Thr in a Japanese patient. These variants were predicted to be pathogenic in silico,were absent in ethnically matched control individuals, and impaired Gαolfcoupling to D1receptors in a bioluminescence energy transfer (BRET) assay. Two additional variants appeared to be benign because they behaved like wild-type samples in the BRET assay (p.Ala311Thr) or were detected in ethnically matched controls (p.Thr92Ala). Both patients with likely pathogenic mutations had craniocervical dystonia with onset in the fifth decade of life. No pathogenic mutations were detected in the patients with hyposmia and Parkinson disease, tardive dyskinesias, or acute dystonic reactions. CONCLUSIONS AND RELEVANCE: Mutations in GNAL can cause craniocervical dystonia in different ethnicities. The BRET assaymay be a useful tool to support the pathogenicity of identified variants in the GNAL gene.
AB - IMPORTANCE: Mutations in the GNAL gene have recently been shown to cause primary torsion dystonia. The GNAL-encoded protein (Gαolf) is important for dopamine D1receptor function and odorant signal transduction.We sequenced all 12 exons of GNAL in 461 patients from Germany, Serbia, and Japan, including 318 patients with dystonia (190 with cervical dystonia), 51 with hyposmia and Parkinson disease, and 92 with tardive dyskinesia or acute dystonic reactions. OBSERVATIONS: We identified the following two novel heterozygous putative mutations in GNAL: p.Gly213Ser in a German patient and p.Ala353Thr in a Japanese patient. These variants were predicted to be pathogenic in silico,were absent in ethnically matched control individuals, and impaired Gαolfcoupling to D1receptors in a bioluminescence energy transfer (BRET) assay. Two additional variants appeared to be benign because they behaved like wild-type samples in the BRET assay (p.Ala311Thr) or were detected in ethnically matched controls (p.Thr92Ala). Both patients with likely pathogenic mutations had craniocervical dystonia with onset in the fifth decade of life. No pathogenic mutations were detected in the patients with hyposmia and Parkinson disease, tardive dyskinesias, or acute dystonic reactions. CONCLUSIONS AND RELEVANCE: Mutations in GNAL can cause craniocervical dystonia in different ethnicities. The BRET assaymay be a useful tool to support the pathogenicity of identified variants in the GNAL gene.
UR - http://www.scopus.com/inward/record.url?scp=84899031959&partnerID=8YFLogxK
U2 - 10.1001/jamaneurol.2013.4677
DO - 10.1001/jamaneurol.2013.4677
M3 - Journal articles
C2 - 24535567
AN - SCOPUS:84899031959
SN - 2168-6149
VL - 71
SP - 490
EP - 494
JO - JAMA Neurology
JF - JAMA Neurology
IS - 4
ER -